The Uromigos

AZGUONC-PRODUCTIONwarmup

<p>Drs. Thomas Zilli and Pierre Blanchard join the podcast at APCCC 2024 to debate the use of radiation therapy in prostate cancer and oligometastatic disease.</p>
<div class="MuiGrid-root MuiGrid-item MuiGrid-grid-xs-12 MuiGrid-grid-sm-12 MuiGrid-grid-md-12 MuiGrid-grid-lg-12 css-15j76c0">
<div>
<div>
<div id="post_content">
<p>Dr. Zilli is an assistant doctor in the service of Radio-Oncology of the University Hospitals of Geneva, and Dr. Blanchard is a professor and serves as Radiation Oncology Clinical section chief at the <span class="org">Institut de Cancérologie Gustave Roussy.</span></p>
<div></div>
</div>
</div>
</div>
</div>


Episode 313: APCCC 2024 Debate - Radiation Therapy in Advanced Disease

Drs. Thomas Zilli and Pierre Blanchard join The Uromigos at APCCC 2024 to debate the use of radiation therapy in prostate cancer and oligometastatic disease.

The Uromigos Episode 313: APCCC 2024 Debate - Radiation Therapy in Advanced Disease

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtable

Uromigos Live

Localized

mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

The Oncology Brothers

Expert Interviews

Journal

Subscribe

Episode 313: APCCC 2024 Debate - Radiation Therapy in Advanced Disease

Related Podcasts